top of page
News, Events and Updates
Search
Apr 3, 2017
New Mechanism of Action Data Related to ANAVEX Compounds Targeting Sigma-1 Receptor
Apr 1, 2017
The Dual Regulation of Oxidative Stress by SIGMA1 Receptors in Physiological/Pathological Conditions
Mar 30, 2017
Targeting M1 Muscarinic & Sigma1 Receptors in Alzheimer's Disease: Reversal of Pathological Hallmark
Mar 30, 2017
Anavex Life Sciences Reports Dismissal of Appeal in the Cortina Lawsuit
Mar 29, 2017
Anavex Presents at AD/PD 2017 Conference
Mar 15, 2017
Anavex Life Sciences to Present at Oppenheimer 27th Annual Healthcare Conference
Mar 13, 2017
Anavex Life Sciences to Present at 14th Annual BIO Asia International Conference
Feb 13, 2017
Anavex Life Sciences Strengthens Board of Directors
Feb 9, 2017
BIO CEO & Investor Conference 2017 Panel "Designing Clinical Trials in 21st Century Cures Paradigm"
Feb 9, 2017
Anavex Life Sciences' CEO Joins BIO CEO & Investor Conference 2017 Panel
Feb 7, 2017
Anavex Reports Fiscal First Quarter 2017 Financial Results
23
24
25
26
27
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
